SCHEMBL27680975

SCHEMBL27680975

CC1CCCCN1c1nccc(C(=O)O)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 2/20 0.47
DYRK1A Q13627 1/20 0.46
HPGD P15428 2/20 0.42
USP2 O75604 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
KHK P50053 2/20 0.41
PDE10A Q9Y233 1/20 0.40
RBP4 P02753 1/20 0.40
TTR P02766 1/20 0.40
GFER P55789 1/20 0.40
CD38 P28907 3/20 0.39
GAA P10253 1/20 0.39
LMNA P02545 2/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30338695 0.89 GFER (0.48) ACACBDYRK1AHPGDBCHEACHE
SCHEMBL13402936 0.79 DYRK1A (0.48) ACACBDYRK1AHPGDUSP2SMN1; SMN2
SCHEMBL28070878 0.76 MAPK8 (0.52) DYRK1AHPGDSMN1; SMN2ACHERBP4
SCHEMBL25591594 0.76 GPR119 (0.48) ACHE
SCHEMBL28087268 0.75 MAPK8 (0.54) DYRK1AHPGDSMN1; SMN2ACHERBP4
SCHEMBL26141096 0.75 ACACB (0.46) ACACBDYRK1AHPGDUSP2SMN1; SMN2
SCHEMBL13384566 0.75 ACACB (0.46) ACACBDYRK1AHPGDUSP2SMN1; SMN2
SCHEMBL26141087 0.75 ACACB (0.46) ACACBDYRK1AHPGDUSP2SMN1; SMN2
SCHEMBL7018239 0.74 GFER (0.43) HPGDUSP2SMN1; SMN2BCHEACHE
SCHEMBL5778634 0.74 SMN1; SMN2 (0.48) DYRK1AHPGDUSP2SMN1; SMN2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101023063-A Azine-carboxamides as anti-cancer agents ASTRAZENECA AB (SE) 2007-08-22 CN disclosed